|
SDCCAG1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.268610E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.252100E-02 |
| Normal-vs-Stage2 |
7.465700E-02 |
| Normal-vs-Stage3 |
1.976790E-01 |
| Normal-vs-Stage4 |
2.575900E-02 |
| Stage1-vs-Stage2 |
6.511200E-01 |
| Stage1-vs-Stage3 |
7.377000E-01 |
| Stage1-vs-Stage4 |
3.648600E-01 |
| Stage2-vs-Stage3 |
5.167600E-01 |
| Stage2-vs-Stage4 |
6.110400E-01 |
| Stage3-vs-Stage4 |
2.445000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.294970E-01 |
| Normal-vs-AfricanAmerican |
9.979900E-02 |
| Normal-vs-Asian |
2.511800E-01 |
| Caucasian-vs-AfricanAmerican |
7.924800E-01 |
| Caucasian-vs-Asian |
7.911000E-01 |
| AfricanAmerican-vs-Asian |
8.572400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.542400E-02 |
| Normal-vs-Female |
5.632400E-01 |
| Male-vs-Female |
7.646000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.405600E-02 |
| Normal-vs-Extreme_Weight |
8.497800E-02 |
| Normal-vs-Obese |
1.615550E-01 |
| Normal-vs-Extreme_Obese |
1.986370E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.126400E-01 |
| Normal_Weight-vs-Obese |
4.576800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.338600E-01 |
| Extreme_Weight-vs-Obese |
6.610200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.020000E-01 |
| Obese-vs-Extreme_Obese |
7.227600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.645600E-01 |
| Normal-vs-Age(41-60Yrs) |
4.216400E-01 |
| Normal-vs-Age(61-80Yrs) |
3.303700E-02 |
| Normal-vs-Age(81-100Yrs) |
1.360490E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.300800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.109850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.006300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.086400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.042500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.131400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.266000E-01 |
| Normal-VS-Type2 PRCC |
3.587700E-04 |
| Normal-VS-KIRP CIMP |
5.178200E-01 |
| Normal-VS-Unclassified PRCC |
3.664800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.558080E-04 |
| Type1 PRCC-VS-KIRP CIMP |
6.872200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.929600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.061800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.830100E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
8.600800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.971500E-04 |
| Normal-vs-N1 |
8.757200E-01 |
| Normal-vs-N2 |
2.462400E-03 |
| N0-vs-N1 |
1.398110E-02 |
| N0-vs-N2 |
7.876200E-02 |
| N1-vs-N2 |
2.313600E-02 |
|
|
